Diagnosis of Alzheimer-type dementia: a preliminary comparison of positron emission tomography and proton magnetic resonance

Journal Article · Fri Nov 16 00:00:00 EST 1984 · JAMA, J. Am. Med. Assoc.; (United States)

DOI:https://doi.org/10.1001/jama.252.19.2750· OSTI ID:6333883

Friedland, R P; Budinger, T F; Brant-Zawadzki, M; Jagust, W J

The use of positron emission tomography with (18F)-2-fluoro-2-deoxy-D-glucose (FDG) to study glucose metabolism in dementia is described and compared with the use of magnetic resonance imaging. These studies suggest that physiological imaging with PET may be superior to MR as it is currently used in the diagnosis of dementia-like diseases. Pet is currently limited to a few centers; however, single photon emission CT can provide regional physiological data without the need for a local cyclotron. 15 references, 2 tables.

• Research Organization: Veterans Administration Medical Center, Martinez, CA
• DOE Contract Number: AC03-76SF00098
• OSTI ID: 6333883
• Journal Information: JAMA, J. Am. Med. Assoc.; (United States), Vol. 252:19
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
NERVOUS SYSTEM DISEASES
DIAGNOSIS
POSITRON COMPUTED TOMOGRAPHY
COMPARATIVE EVALUATIONS
DIAGNOSTIC USES
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
FLUORINE 18
GLUCOSE
IMAGES
METABOLISM
PATIENTS
RADIOPHARMACEUTICALS
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CARBOHYDRATES
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
EMISSION COMPUTED TOMOGRAPHY
FLUORINE ISOTOPES
HEXOSES
HOURS LIVING RADIOISOTOPES
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
MONOSACCHARIDES
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
RADIOISOTOPES
SACCHARIDES
TOMOGRAPHY
USES
550601* - Medicine- Unsealed Radionuclides in Diagnostics
550600 - Medicine